Biodexa Pharmaceuticals Plc (BDRX)
D
Pipeline Grade
Drug Pipeline (0 Assets)
No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.
Upcoming Catalysts
No upcoming catalysts detected for this company.
Active Clinical Trials (2)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT06950385 | Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis | PHASE3 | Recruiting | 168 |
| NCT04230499 | Trial of ERapa to Prevent Progression in Familial Adenomatous Polyposis Patients Under Active Surveillance | PHASE2 | Active Not Recruiting | 30 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.